These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro activity of tobramycin and gentamicin against Enterobacteriaceae and gentamicin-resistant, carbenicillin-resistant Pseudomonas aeruginosa. Watanakunakorn C, Bannister T. Curr Ther Res Clin Exp; 1975 May; 17(5):488-96. PubMed ID: 805033 [No Abstract] [Full Text] [Related]
6. Global and effective synergism of amikacin, gentamicin or tobramycin when combined with carbenicillin against Pseudomonas aeruginosa. Ximenes J, Hirai CK, Takenaka IM. J Int Med Res; 1979 May; 7(5):375-8. PubMed ID: 115732 [Abstract] [Full Text] [Related]
9. In vitro evaluation of cefoperazone compared to other antipseudomonal drugs. Nicoletti P, Mazzei T, Lamanna S. G Batteriol Virol Immunol; 1981 May; 74(1-6):3-7. PubMed ID: 6458526 [No Abstract] [Full Text] [Related]
10. [Bacteriological studies on the therapy of bacillus pyocyaneus infections]. Metz H, Ohgke H, Hartmann I. Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):342-8. PubMed ID: 809372 [Abstract] [Full Text] [Related]
11. [Antibiotic therapy of Pseudomonas aeruginosa infections: possibilities and limitations]. Voiculescu M, Golăescu M, Giuglea M, Mătuşa R, Alexandru S. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978 Oct; 30(2):157-64. PubMed ID: 26955 [No Abstract] [Full Text] [Related]
13. Effects of sputum from patients with cystic fibrosis on the activity in vitro of 5 antimicrobial drugs on Pseudomonas aeruginosa. Davis SD, Bruns WT. Am Rev Respir Dis; 1978 Jan; 117(1):176-8. PubMed ID: 413461 [Abstract] [Full Text] [Related]